362 related articles for article (PubMed ID: 10435397)
1. Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain.
Timmerman W; Heijmen M; Westerink BH; Bruggeman R; den Boer JA
Psychopharmacology (Berl); 1999 Jun; 144(3):286-94. PubMed ID: 10435397
[TBL] [Abstract][Full Text] [Related]
2. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
Bruggeman R; Westerink BH; Timmerman W
Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
4. Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol.
Lee MD; Clifton PG
Pharmacol Biochem Behav; 2002; 71(1-2):147-54. PubMed ID: 11812517
[TBL] [Abstract][Full Text] [Related]
5. Combined 5-HT2/D2 receptor blockade inhibits the firing rate of SNR neurons in the rat brain.
Bruggeman R; Heeringa M; Westerink BH; Timmerman W
Prog Neuropsychopharmacol Biol Psychiatry; 2000 May; 24(4):579-93. PubMed ID: 10958152
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics and single-cell activity in the rat superior colliculus.
Broerse A; Timmerman W; Westerink BH; Den Boer JA
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):327-33. PubMed ID: 11822350
[TBL] [Abstract][Full Text] [Related]
7. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
Jardemark KE; Liang X; Arvanov V; Wang RY
Neuroscience; 2000; 100(1):1-9. PubMed ID: 10996453
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine.
Sebens JB; Koch T; Ter Horst GJ; Korf J
Eur J Pharmacol; 1998 Jul; 353(1):13-21. PubMed ID: 9721035
[TBL] [Abstract][Full Text] [Related]
9. Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.
Hartfield AW; Moore NA; Clifton PG
Psychopharmacology (Berl); 2003 May; 167(2):115-22. PubMed ID: 12658526
[TBL] [Abstract][Full Text] [Related]
10. Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats.
Porter JH; Varvel SA; Vann RE; Philibin SD; Wise LE
Psychopharmacology (Berl); 2000 Apr; 149(2):189-93. PubMed ID: 10805615
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Markianos M; Hatzimanolis J; Lykouras L
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
[TBL] [Abstract][Full Text] [Related]
12. Insight in persons with schizophrenia: effects of switching from conventional neuroleptics to atypical antipsychotics.
Aguglia E; De Vanna M; Onor ML; Ferrara D
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1229-33. PubMed ID: 12502008
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of antipsychotic drugs.
Meibach RC
Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
[No Abstract] [Full Text] [Related]
14. The effects of novel antipsychotics on glucose and lipid levels.
Wirshing DA; Boyd JA; Meng LR; Ballon JS; Marder SR; Wirshing WC
J Clin Psychiatry; 2002 Oct; 63(10):856-65. PubMed ID: 12416594
[TBL] [Abstract][Full Text] [Related]
15. Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation.
Duncan GE; Miyamoto S; Lieberman JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):999-1005. PubMed ID: 12626664
[TBL] [Abstract][Full Text] [Related]
16. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.
Shirazi-Southall S; Rodriguez DE; Nomikos GG
Neuropsychopharmacology; 2002 May; 26(5):583-94. PubMed ID: 11927183
[TBL] [Abstract][Full Text] [Related]
17. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.
Weiner I; Schiller D; Gaisler-Salomon I; Green A; Joel D
Behav Pharmacol; 2003 May; 14(3):215-22. PubMed ID: 12799523
[TBL] [Abstract][Full Text] [Related]
18. Dosing the antipsychotic medication olanzapine.
Nemeroff CB
J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.
Stockton ME; Rasmussen K
Neuropsychopharmacology; 1996 Feb; 14(2):97-105. PubMed ID: 8822532
[TBL] [Abstract][Full Text] [Related]
20. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
